Atlas Trials

Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia

Clinical trial NCT02345382 · COMPLETED

Trial details

NCT number
NCT02345382
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Leukemia
Start date
2015-02-19
Primary completion
2016-09-14
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.